AU2003269219A1 - Process and intermediates for the preparation of the thienopyrrole derivatives - Google Patents

Process and intermediates for the preparation of the thienopyrrole derivatives Download PDF

Info

Publication number
AU2003269219A1
AU2003269219A1 AU2003269219A AU2003269219A AU2003269219A1 AU 2003269219 A1 AU2003269219 A1 AU 2003269219A1 AU 2003269219 A AU2003269219 A AU 2003269219A AU 2003269219 A AU2003269219 A AU 2003269219A AU 2003269219 A1 AU2003269219 A1 AU 2003269219A1
Authority
AU
Australia
Prior art keywords
alkyl
formula
carbamoyl
amino
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003269219A
Other languages
English (en)
Inventor
Paul Michael Murray
Jeremy Stephen Parker
Paul Schofield
Andrew Stocker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of AU2003269219A1 publication Critical patent/AU2003269219A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/36—Nitrogen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
AU2003269219A 2002-10-03 2003-09-29 Process and intermediates for the preparation of the thienopyrrole derivatives Abandoned AU2003269219A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0222912.8 2002-10-03
GBGB0222912.8A GB0222912D0 (en) 2002-10-03 2002-10-03 Novel process and intermediates
PCT/GB2003/004217 WO2004031194A1 (en) 2002-10-03 2003-09-29 Process and intermediates for the preparation of the thienopyrrole derivatives

Publications (1)

Publication Number Publication Date
AU2003269219A1 true AU2003269219A1 (en) 2004-04-23

Family

ID=9945219

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003269219A Abandoned AU2003269219A1 (en) 2002-10-03 2003-09-29 Process and intermediates for the preparation of the thienopyrrole derivatives

Country Status (13)

Country Link
US (1) US7411074B2 (https=)
EP (1) EP1549654A1 (https=)
JP (1) JP2006505541A (https=)
KR (1) KR20050061503A (https=)
CN (1) CN100378106C (https=)
AU (1) AU2003269219A1 (https=)
BR (1) BR0314966A (https=)
CA (1) CA2500145A1 (https=)
GB (1) GB0222912D0 (https=)
MX (1) MXPA05003327A (https=)
NO (1) NO20051393L (https=)
WO (1) WO2004031194A1 (https=)
ZA (1) ZA200502340B (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0205170D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205176D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205162D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205166D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205175D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205165D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0222909D0 (en) 2002-10-03 2002-11-13 Astrazeneca Ab Novel process and intermediates
JP2007517056A (ja) 2003-12-29 2007-06-28 セプラコア インコーポレーテッド ピロール及びピラゾールｄａａｏ阻害剤
NZ569608A (en) 2006-01-06 2011-09-30 Sepracor Inc Tetralone-based monoamine reuptake inhibitors
US20070203111A1 (en) 2006-01-06 2007-08-30 Sepracor Inc. Cycloalkylamines as monoamine reuptake inhibitors
US7884124B2 (en) 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
US7902252B2 (en) 2007-01-18 2011-03-08 Sepracor, Inc. Inhibitors of D-amino acid oxidase
CA2688493C (en) 2007-05-31 2016-04-19 Sepracor Inc. Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU364613A1 (ru) * 1970-11-27 1972-12-28 Всесоюзный научно исследовательский химико фармацевтический институт имени С. Орджоникидзе Способ получения производных 2-аминотиено-
JPH01242587A (ja) * 1988-03-25 1989-09-27 Sankyo Co Ltd 縮環オキサゾロチエノピリミジン誘導体
GB9302622D0 (en) 1993-02-10 1993-03-24 Wellcome Found Heteroaromatic compounds
DE60007592T2 (de) 1999-09-30 2004-09-16 Pfizer Products Inc., Groton Bicyclische Pyrrolylamide als Glycogenphosphorylase-Inhibitoren
AU778042B2 (en) 1999-10-19 2004-11-11 Merck & Co., Inc. Tyrosine kinase inhibitors
SE9903998D0 (sv) 1999-11-03 1999-11-03 Astra Ab New compounds
JP2001294572A (ja) 2000-02-09 2001-10-23 Dai Ichi Seiyaku Co Ltd 新規スルホニル誘導体
EP1136071A3 (en) 2000-03-22 2003-03-26 Pfizer Products Inc. Use of glycogen phosphorylase inhibitors
GB0017676D0 (en) 2000-07-19 2000-09-06 Angeletti P Ist Richerche Bio Inhibitors of viral polymerase
GB0021831D0 (en) * 2000-09-06 2000-10-18 Astrazeneca Ab Chemical compounds
MXPA03000966A (es) 2002-02-28 2003-09-04 Pfizer Prod Inc Agentes antidiabeticos.
GB0205170D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205162D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205176D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205166D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205165D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205175D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
JPWO2003091213A1 (ja) 2002-04-25 2005-09-02 アステラス製薬株式会社 新規なアミド誘導体又はその塩
EP1543011B1 (en) 2002-09-06 2006-05-03 Janssen Pharmaceutica N.V. Thienopyrrolyl and furanopyrrolyl compounds and their use as histamine h4 receptor ligands
GB0222909D0 (en) 2002-10-03 2002-11-13 Astrazeneca Ab Novel process and intermediates
WO2004041780A2 (en) 2002-11-07 2004-05-21 Pfizer Products Inc. N-(indole-2-carbonyl) amides as anti-diabetic agents
US7098235B2 (en) 2002-11-14 2006-08-29 Bristol-Myers Squibb Co. Triglyceride and triglyceride-like prodrugs of glycogen phosphorylase inhibiting compounds
JP2004196702A (ja) 2002-12-18 2004-07-15 Yamanouchi Pharmaceut Co Ltd 新規なアミド誘導体又はその塩
JP4109288B2 (ja) 2002-12-25 2008-07-02 第一三共株式会社 ジアミン誘導体
BRPI0409465A (pt) 2003-04-17 2006-05-02 Pfizer Prod Inc derivados de carboxamida como agentes antidiabéticos
BRPI0409952A (pt) 2003-04-30 2006-04-25 Pfizer Prod Inc agentes anti-diabéticos
WO2004113345A1 (ja) 2003-06-20 2004-12-29 Japan Tobacco Inc. 縮合ピロール化合物及びその医薬用途
GB0318463D0 (en) 2003-08-07 2003-09-10 Astrazeneca Ab Chemical compounds
GB0318464D0 (en) 2003-08-07 2003-09-10 Astrazeneca Ab Chemical compounds
GB0319690D0 (en) 2003-08-22 2003-09-24 Astrazeneca Ab Chemical compounds
GB0319759D0 (en) 2003-08-22 2003-09-24 Astrazeneca Ab Chemical compounds
WO2005020986A1 (en) 2003-08-29 2005-03-10 Astrazeneca Ab Heterocyclic amide derivatives which posses glycogen phosphorylase inhibitory activity
WO2005020985A1 (en) 2003-08-29 2005-03-10 Astrazeneca Ab Indolamide derivatives which possess glycogen phosphorylase inhibitory activity
GB0320422D0 (en) 2003-08-30 2003-10-01 Astrazeneca Ab Chemical compounds

Also Published As

Publication number Publication date
CA2500145A1 (en) 2004-04-15
BR0314966A (pt) 2005-08-02
EP1549654A1 (en) 2005-07-06
CN100378106C (zh) 2008-04-02
JP2006505541A (ja) 2006-02-16
US7411074B2 (en) 2008-08-12
NO20051393L (no) 2005-04-20
US20060035953A1 (en) 2006-02-16
GB0222912D0 (en) 2002-11-13
MXPA05003327A (es) 2005-07-05
ZA200502340B (en) 2005-09-19
CN1688587A (zh) 2005-10-26
WO2004031194A1 (en) 2004-04-15
KR20050061503A (ko) 2005-06-22

Similar Documents

Publication Publication Date Title
US7307174B2 (en) Process and intermediates for the preparation of thienopyrrole derivatives
AU2003269219A1 (en) Process and intermediates for the preparation of the thienopyrrole derivatives
ES2758027T3 (es) Intermedios para la síntesis de inhibidores de enzimas activadoras de actividad E1
ES2362660T3 (es) Cristalización de formas sólidas de sales de adición de clopidogrel.
Lee et al. Synthesis of 5-(7-hydroxyhept-3-enyl)-1, 2-dithiolan-3-one 1-oxide, a core functionality of antibiotic leinamycin
AU2019360210B2 (en) 6-Mercaptopurine nucleoside analogues
BRPI0618131A2 (pt) derivado de alquilcarbamoil naftalenilóxi-octenoilidroxiamida tendo atividade inibitória contra histona desacetilase e sua preparação
CA1341159C (en) Pure enantiomers of 4,5-disubstituted .alpha.-butyrolactams, process for their preparation, and their use
KR20110021764A (ko) 디하이드로티에노［３，２－ｄ］피리미딘 디올 및 유사한 피리미딘 디올의 합성
MXPA04005863A (es) Compuestos inhibidores de lipasa pancreatica, su sintesis y uso.
EA008055B1 (ru) Кристаллические формы оланзапина и способы их получения
Mashraqui et al. Synthesis of 3, 4-Bis (4′-Methylphenyl) Thieno [2, 3-b] Thiophene: First Example of Peri-Diaryl Thienothiophene
Demirayak et al. A facile synthesis of some thieno/furo‐[2, 3‐d] pyrimidine‐2‐yl‐thioacetic acid derivatives
Abdelrazek et al. Heterocyclic synthesis with nitriles: synthesis of some novel thiophene and thieno [2, 3-d] pyrimidine derivatives
Puterová et al. Synthesis of novel water soluble onium salts and thieno [3, 4-c] thiolactones–precursors of conductive materials derived from substituted 2-aminothiophenes
CN121627625A (zh) 一种利用1,3-二羰基化合物和炔酸酯合成吡喃烷酮衍生物的方法
AU2013204601B2 (en) Process for the synthesis of E1 activating enzyme inhibitors
HRP980056A2 (en) Efficient synthesis of a 1,4-dihidro-2h-3,1-benzoxazin-2-one
JPS5852995B2 (ja) フルフラ−ル誘導体の製造法
KR20020068140A (ko) [(2-옥소-3-테트라히드로티에닐카바모일)-메틸티오]아세트산의 제조방법
DE19624291A1 (de) Pharmazeutische Mittel, die Isoxazolodiazepinone enthalten
HK1151524B (en) Synthesis of dihydrothieno[3,2-d]pyrimidine diols and similar pyrimidine diols

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted